CIK 0001621227
- Non-accelerated filer
- Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1235430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-11 | Bertrand William C JR Chief Operating Officer | Sale | −4,009 | $0.84 | $3K | 6,104 |
| 2024-01-11 | Lunger John Chief Patient Supply Officer | Sale | −4,009 | $0.84 | $3K | 6,104 |
| 2024-01-11 | Norry Elliot Chief Medical Officer | Sale | −4,009 | $0.84 | $3K | 6,104 |
| 2024-01-11 | Rawcliffe Adrian Chief Executive Officer | Sale | −11,945 | $0.84 | $10K | 18,395 |
| 2023-09-01 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,403 | $0.78 | $2K | 3,449 |
| 2023-08-01 | Lunger John Chief Patient Supply Officer | Sale | −3,096 | $0.91 | $3K | 4,718 |
| 2023-07-10 | Menzel Garry E Director | Sale | −47,702 | $0.91 | $43K | 75,056 |
| 2023-06-27 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,333 | $0.92 | $2K | 3,519 |
| 2023-01-31 | Piccina Cintia Chief Commercial Officer | Sale | −11,890 | $1.87 | $22K | 19,535 |
| 2023-01-17 | Lunger John Chief Patient Supply Officer | Sale | −4,440 | $1.86 | $8K | 7,264 |
| 2023-01-17 | Bertrand William C JR Chief Operating Officer | Sale | −4,440 | $1.86 | $8K | 7,264 |
| 2023-01-17 | Norry Elliot Chief Medical Officer | Sale | −2,159 | $1.86 | $4K | 3,491 |
| 2023-01-17 | Rawcliffe Adrian Chief Executive Officer | Sale | −10,057 | $1.86 | $19K | 13,351 |
| 2023-01-12 | Bertrand William C JR Chief Operating Officer | Sale | −4,973 | $1.71 | $8K | 8,121 |
| 2023-01-12 | Lunger John Chief Patient Supply Officer | Sale | −4,973 | $1.71 | $8K | 8,121 |
| 2023-01-12 | Norry Elliot Chief Medical Officer | Sale | −7,449 | $1.71 | $13K | 12,191 |
| 2023-01-12 | Rawcliffe Adrian Chief Executive Officer | Sale | −18,763 | $1.71 | $32K | 24,882 |
| 2023-01-11 | Bertrand William C JR Chief Operating Officer | Sale | −3,843 | $1.75 | $7K | 6,270 |
| 2023-01-11 | Lunger John Chief Patient Supply Officer | Sale | −3,843 | $1.75 | $7K | 6,270 |
| 2023-01-11 | Norry Elliot Chief Medical Officer | Sale | −3,843 | $1.75 | $7K | 6,270 |
Page 3 of 7 · 140 trades